Literature DB >> 21670844

Absence of "rebound" platelet hyperreactivity following cessation of prasugrel.

Joseph A Jakubowski, Ying G Li, Christopher D Payne, David S Small, Kenneth J Winters.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21670844     DOI： 10.1160/TH10-11-0764

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  4 in total

1.  Legacy of blood: does prasugrel inhibit megakaryocytes and do juvenile platelets inherit this inhibition?

Authors:  Carlos G Santos-Gallego
Journal:  Haematologica       Date:  2015-09       Impact factor: 9.941

Review 2.  Coming safely to a stop: a review of platelet activity after cessation of antiplatelet drugs.

Authors:  Isobel Ford
Journal:  Ther Adv Drug Saf       Date:  2015-08

3.  The effect of cessation of 2nd generation P2Y12 inhibitor therapy on platelet reactivity in patients 1 year after acute myocardial infarction.

Authors:  Guy Witberg; Jalal Bathish; Tamir Bental; Dorit Leshem-Lev; Abid Assali; Ran Kornowski; Eli Lev
Journal:  J Thromb Thrombolysis       Date:  2018-10       Impact factor: 2.300

4.  Gradual increase in thrombogenicity of juvenile platelets formed upon offset of prasugrel medication.

Authors:  Constance C F M J Baaten; Leo F Veenstra; Rick Wetzels; Johanna P van Geffen; Frauke Swieringa; Susanne M de Witt; Yvonne M C Henskens; Harry Crijns; Sven Nylander; J J J van Giezen; Johan W M Heemskerk; Paola E J van der Meijden
Journal:  Haematologica       Date:  2015-06-25       Impact factor: 9.941
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.